Early research (Phase 1)Study completedNCT00503347
What this trial is testing
Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
Who this might be right for
Hepatitis C VirusHiv Infections
Peregrine Pharmaceuticals 24